REMDESIVIR

13295 reported adverse events

Drug classes: SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC]

These side effects are most commonly reported by patients taking REMDESIVIR:

# Side effect Count
0 OFF LABEL USE 2245
1 ALANINE AMINOTRANSFERASE INCREASED 935
2 COVID-19 919
3 DRUG INEFFECTIVE 768
4 DEATH 762
5 BRADYCARDIA 652
6 ACUTE KIDNEY INJURY 630
7 ASPARTATE AMINOTRANSFERASE INCREASED 629
8 RESPIRATORY FAILURE 552
9 COVID-19 PNEUMONIA 505
See all common reactions for REMDESIVIR

REMDESIVIR is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CLINICAL TRIAL PARTICIPANT 21 0.3684
1 MASKED FEVER 5 0.3571
2 PULMONARY TRICHOSPORONOSIS 8 0.3478
3 COVID-19 TREATMENT 21 0.3088
4 MITRAL PERFORATION 4 0.2500
5 SARS-COV-2 VIRAEMIA 12 0.2069
6 LACTOBACILLUS BACTERAEMIA 4 0.1905
7 SARS-COV-2 RNA INCREASED 11 0.1618
8 PARAVENOUS DRUG ADMINISTRATION 6 0.1395
9 COINFECTION 9 0.1304
See all enriched reactions for REMDESIVIR